Results: Regression models incorporated clinical and demographic factors. Compared with the English-speaking cohort, non–English-speaking cases with bilingual physicians had similar rates of resource utilization. Cases with an interpreter showed no difference in test costs, were least likely to be tested (odds ratio [OR], 0.73; 95% confidence interval [CI], 0.56-0.97), more likely to be admitted (OR, 1.7; 95% CI, 1.1-2.8), and no more likely to receive intravenous fluids, but had longer lengths of visit (+16 minutes; 95% CI, 6.2-26 minutes). The barrier cohort without a professional interpreter had a higher incidence (OR, 1.5; 95% CI, 1.042.2) and cost (+$5.78; 95% CI, $0.24-$11.21) for testing and was most likely to be admitted (OR, 2.6; 95% CI, 1.4-4.5) and to receive intravenous hydration (OR, 2.2; 95% CI, 1.24.3), but showed no difference in length of visit. Conclusion: Decision making was most cautious and expensive when non–English-speaking cases were treated in the absence of a bilingual physician or professional interpreter.
No takes yet. Share an insight, caveat, or question.
Hampers et al. (2002) studied this question.